Skip to main content
SpringerLink
Log in

Morphology of Cancer Precursor Lesions

  • Chapter
Cancer Precursors

  • 348 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ponten J. Cell biology of precancer. In: Ponten J (ed) Precancer: biology, importance and possible prevention. Cancer Surv 1998; 32:5–35.

    Google Scholar 

  2. Henson DE, Albores-Saavedra J. Pathology of Incipient Neoplasia, 3rd ed. Oxford: Oxford University Press, 2001.

    Google Scholar 

  3. Cotran RS, Kumar V, Collins T. Neoplasia. In: Cotran RS, Kumar V, Collins T (eds) Robbins Pathologic Basis of Disease, 6th ed. Philadelphia: WB Saunders Company, 1999, 260–327.

    Google Scholar 

  4. Fleming ID, Cooper JS, Henson DE, et al. (eds) AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997.

    Google Scholar 

  5. Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124:979–94.

    PubMed  CAS  Google Scholar 

  6. Epstein JI, Amin MB, Reuter VE, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998; 22:1435–48.

    PubMed  CAS  Google Scholar 

  7. Richart RM. Natural history of cervical intraepithelial neoplasia. Clin Obstet Gynecol 1968; 5:748–84.

    Google Scholar 

  8. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses: developed and approved at the National Cancer Institute Workshop in Bethesda, Maryland, December 12–13, 1988. Hum Pathol 1990; 7:704–8.

    Google Scholar 

  9. The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, April 29–30, 1991. Acta Cytol 1993; 37:115–24.

    Google Scholar 

  10. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61:759–67.

    Article  PubMed  CAS  Google Scholar 

  11. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87:159–70.

    Article  PubMed  CAS  Google Scholar 

  12. Greenlee RT, Murray T, Bolden S, et al. Cancer Statistics 2000, CA Cancer J Clin 2000; 50:7–33.

    PubMed  CAS  Google Scholar 

  13. Percy C (ed) Histology of cancer. Incidence and prognosis: SEER Population-Based Data, 1973–1987. Cancer Suppl 1995; 77:1–421.

    Google Scholar 

  14. Hammond MEH, Fitzgibbons PL, Compton CC, et al. College of American Pathologists Conference XXXV: solid tumor prognostic factors—which, how, and so what? summary document and recommendations for implementation. Arch Pathol Lab Med 2000; 124:958–65.

    PubMed  CAS  Google Scholar 

  15. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 3:273–9.

    Google Scholar 

  16. Hayes DF, Bast RC, Desch CE, et al. Tumor marker utility grading scheme: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst 1996; 88:1456–66.

    PubMed  CAS  Google Scholar 

  17. Hayes DF, Trock B, Harris AL. Assessing the clinical impact of prognostic factors: when is “statistically significant” clinically useful? Breast Cancer Res 1998; 52:305–19.

    CAS  Google Scholar 

  18. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996; 274:998–1001.

    Article  PubMed  CAS  Google Scholar 

  19. Fend F, Raffeld M. Laser capture microdissection in pathology. J Clin Pathol 2000; 53:666–72.

    Article  PubMed  CAS  Google Scholar 

  20. Webb T. Laser capture microdissection comes into mainstream use. J Natl Cancer Inst 2000; 92:1710–11.

    PubMed  CAS  Google Scholar 

  21. Perou CM, Brown PO, Botsetin D. Tumor classification using gene expression patterns from DNA microarrays. Mol Med Today 2000; 6: 67–76.

    Google Scholar 

  22. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286:531–7.

    Article  PubMed  CAS  Google Scholar 

  23. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999; 96:9212–17.

    Article  PubMed  CAS  Google Scholar 

  24. Wang E, Marincola FM. A natural history of melanoma: serial gene expression analysis. Immunol Today 2000; 21:619–23.

    Article  PubMed  CAS  Google Scholar 

  25. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844–7.

    Article  PubMed  CAS  Google Scholar 

  26. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000; 80:1943–9.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael B. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Oncology and Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  2. Division of Cancer Epidemiology, McGill University, Montreal, Quebec, H2W 1S6, Canada

    Eduardo L. Franco MPH, DrPH (Professor, Director) (Professor, Director)

  3. Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY, 10461, USA

    Thomas E. Rohan MB, BS, PhD (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Cohen, M.B. (2002). Morphology of Cancer Precursor Lesions. In: Franco, E.L., Rohan, T.E. (eds) Cancer Precursors. Springer, New York, NY. https://doi.org/10.1007/0-387-21605-7_3

Download citation

  • DOI: https://doi.org/10.1007/0-387-21605-7_3

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95188-1

  • Online ISBN: 978-0-387-21605-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation